Using scRNA-seq in clinical lung cancer tissue samples and EGFR-TKI-resistant cell models, they found that upregulation of CD74 inhibited apoptosis and induced acquired resistance to osimertinib, facilitating tumor regeneration. Here, EGFR is linked to lung carcinoma.